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Background, Objectives/Goal, Methods/Design, Results, Conclusions limited to 500 words

Background:
Lymphocytic lobulitis (LL) is a benign disease process of the breast that is associated with various
autoimmune diseases such as Type 1 diabetes mellitus (T1D). It occurs most often in premenopausal women. This association between LL and T1D reported in the adult literature can be
as high as 69.7% and LL is often referred to as diabetic mastopathy (1). To our knowledge there are
no reported cases of LL in the pediatric population.
Objectives/Goal: To describe a case of lymphocytic lobulitis in a pediatric patient without known
T1D.
Methods/Design: N/A
Results: N/A

Conclusions: Our case involved a previously healthy 16-year-old female with bilateral mammary
hyperplasia. Concurrent intertrigo was present bilaterally beneath each breast. Significant
autoimmune diseases were reported in the family including autoimmune hypothyroidism,
rheumatoid arthritis, inflammatory bowel disease, and systemic lupus erythematosus. Her breast
exam demonstrated mammary hypertrophy with grade 3 ptosis, but no discreet breast masses
were appreciated. Bilateral reduction mammoplasty was undertaken without complications.
Histopathology of the resected breast tissue revealed mammary hypertrophy consistent with
juvenile macromastia with associated LL. Post-operative issues included edema, breast erythema
and pruritus. A short course of prednisolone was prescribed and these symptoms resolved over the
next few weeks. Due to the strong association with autoimmunity, an Endocrine referral was made.
The patient reported no polyuria, polydipsia or weight loss. There were also no GI symptoms, no
recent hair loss, and her menses were reported as regular. No goiter was palpated. Biochemical
evaluation was negative for celiac and autoimmune thyroid disease. Fasting blood glucose and
HBA1c were also normal. Autoimmune markers for T1D are currently pending.
This case is significant as lymphocytic lobulitis has not previously been reported in the pediatric
population. Even though autoimmunity has not been discovered in our patient at this time, it is
important for pediatricians to understand the known association between LL and autoimmunity
and appreciate any potential future risk. It is also important to understand that associations are not
necessarily causal, and there is a paucity of information regarding her prognosis.
1. Diabetes Care, Vol 25, No 1, Jan 2002

